Category : Search result: diabetes remission


NHS Prescribes App to Reverse Type 2 Diabetes

The NHS is rolling out a revolutionary digital health programme, Oviva, to help thousands of patients in England put Type 2 diabetes into remission through structured weight loss support, slashing long-term healthcare costs.

NHS prescribes weight-loss jabs for diabetes treatment

The NHS is revolutionising Type 2 diabetes treatment by prescribing weight-loss injections like Ozempic, following new NICE guidance that could help thousands achieve remission through groundbreaking medication.

Novo Nordisk reduces Ozempic and Wegovy prices

Novo Nordisk has announced significant price cuts for its popular weight-loss and diabetes drugs, Ozempic and Wegovy, making them more accessible to patients across the UK.

Ozempic & Mounjaro Prices Rise Due to Trump Tariffs

Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.

Omega-3 may lower heart disease risk in diabetics

New research suggests that omega-3 fatty acids from fish oil could help lower the risk of heart disease in people with type 2 diabetes, offering a potential dietary boost for cardiovascular health.

Omega-3 may reduce diabetes risk, study finds

A breakthrough study suggests omega-3 fatty acids, commonly found in fish oil, may reduce the risk of developing type 2 diabetes. Learn how this supplement could revolutionise preventive healthcare.

Horses detect heart attacks and diabetes

Groundbreaking research suggests horses have an extraordinary ability to detect heart attacks and diabetes in humans, potentially revolutionising early diagnosis.

Eli Lilly hikes Mounjaro price in UK for 2025

Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.

NHS weight loss drug price hike sparks outrage

The NHS is under fire after the cost of the popular weight loss drug Mounjaro surged, leaving patients struggling to afford treatment. Experts warn of a growing health inequality crisis.

Ozempic and Wegovy may increase risk of vision loss

A recent study suggests that popular weight loss drugs Ozempic and Wegovy, containing semaglutide, may increase the risk of a rare eye condition leading to vision loss. Experts urge caution.

Page 1 of 3